| NCT Number | NCT06945380 |
| Lead Sponsor | Mayo Clinic
Collaborators: National Cancer Institute (NCI), Collinge and Associates, Inc., IRIS Media Inc |
| Conditions | Chemotherapy-Induced Peripheral Neuropathy, Malignant Solid Neoplasm, Hematopoietic and Lymphatic System Neoplasm |
| Enrollment | 300 participants |
| Start Date | 2025-05-27 |
| Primary Completion | 2026-05-31 (estimated) |
| Study Completion | 2026-05-31 (estimated) |
| Updated on ClinicalTrials.gov | 2026-05-06 |